With the upcoming federal elections on 26 September 2021, Germany is facing a possible turning point in cannabis policy. The last reform of the regulations on industrial hemp was 25 years ago, and medicinal cannabis was only legalised in 2017. All leading parties agree that a liberalization of recreational cannabis use must also take place. The webinar will discuss the results of the federal election, how likely full legalization will be and how it will affect the medical cannabis market.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|Antrag auf Erteilung einer Erlaubnis (186.3 KB)||25 Pages||Available after Purchase|
|Entwurf eines Cannabiskontrollgesetzes (464.3 KB)||68 Pages||Available after Purchase|
|DIE KOSTEN DER CANNABIS-PROHIBITION IN DEUTSCHLAND (1.2 MB)||64 Pages||Available after Purchase|
Kai has been a business and corporate lawyer in Germany for almost 17 years gaining wide range of experiences in the process. He is very familiar with the interconnectivity between national and European regulations, especially in regard to consumer protection, product safety and emerging new cannabis products. He has engaged in advocacy relating to cannabis beginning in early stages of his studies at Philipps University Marburg when the German Supreme Court ruled that small amounts of cannabis should not be criminalized. After medical cannabis was legalized in Germany, Kai started a legal blog (canna-biz.legal) on all the relevant new developments in the emerging cannabis market and became a legal expert especially for CBD products.
He regularly speaks at international cannabis conferences on topics of the German and European legal framework. Lastly he spoke at the ICBC Virtual Global Symposium in June 2020, at the First Asian Hemp Summit 2019 in Hong Kong and at the Cannabis Law Institute 2019 in New York. He has published articles on the Prohibition Partners platform and was cited by the Cannabis Law Report as well as the Canadian Globe and Mail. Kai co-founded the International Cannabis Bar Association which with an event in Berlin in April 2019. He consults major CBD and medical cannabis companies as well as a reputable online knowledge portal for medical cannabis and CBD.
Kai is member of the European Hemp Association (EIHA), the German Hemp Association (DHV), Law Enforcement Against Prohibition (LEAP Germany), and Advisory Board Member of the International Cannabis Bar Association (INCBA).
Areas of Law:
born in 1972 in Löhne/Westf., Germany
studied law at the universities of Marburg, Adelaide (Australia), Cologne, and Berlin, first and second state exam (law degree)
worked as a legal expert at the press center of the German Federal Diet, worked for the Berlin District Court, for the Director of Public Prosecution in Berlin, for the Office for the Protection of the Constitution in Berlin and the Hong Kong Consulate General
www.canna-biz.legal (the legal cannabis blog)
Jakob Sons is co-founder, Managing Director and General Counsel of Cansativa in Germany. Jakob studied law at the Universities of Heidelberg and Würzburg and started his professional carrier as a corporate and commercial litigation lawyer with international law firms based in Frankfurt am Main. He is a PhD candidate at the University of Marburg focusing on Pharmaceutical Law and the national and international regulation of Cannabis as a pharmaceutical product. Jakob is leading the legal and regulatory team at Cansativa and, inter alia, managed the GMP/GDP-certification of two German sites of the company and prepared the first importation of product samples from LatAm and Australia.
Daniel Haymann is an attorney with the leading Swiss law firm Froriep. His main area of practice is in corporate and commercial law with a focus on private equity and venture capital transactions, as well as on regulatory law in the cannabis industry. He established the first dedicated cannabis practice in Switzerland and advises investors, start-ups, and vertically integrated companies in the cannabis industry along the value chain. Prior to embarking on a second career as an attorney, Daniel gained over 12 years of experience in the trading, mining, energy, and related industries based out of Switzerland, Singapore, and Hong Kong working for multinational corporations as a trader and in managerial positions.
Please wait ...